What top creators are saying about Zepbound(ZEPBOUND)

Eli Lilly injectable GLP-1 medication for weight management.

1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Based on 1 scored insight about Zepbound.

Mixed
avg +0.00
0 bullish1 neutral0 bearish

Top creators covering Zepbound (ZEPBOUND)

The 1 sources with the most insights about Zepbound on Kazuha.

Latest insights about Zepbound (ZEPBOUND)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Yesterday

Neutral
Target: $299 self-pay price

Zepbound was discussed as a Lilly product available through the Hims partnership, which could make access more seamless.

Discussed alongside Zepbound (ZEPBOUND)

Other assets that creators frequently mention in the same content as Zepbound.

Frequently asked

Which podcasters and creators cover Zepbound (ZEPBOUND) the most?

The most active sources covering Zepbound (ZEPBOUND) on Kazuha are @BeatTheDenominator. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Zepbound (ZEPBOUND) are on Kazuha?

Kazuha has indexed 1 AI-extracted insight about Zepbound (ZEPBOUND) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Zepbound (ZEPBOUND)?

Creators covering Zepbound (ZEPBOUND) most frequently also discuss COST, AAPL, HIMS, TSLA, FOUNDAYO. See the "Discussed alongside" section above for full asset pages.